SMITH CHARLES A

CRO Charles Smith sells 8,500 MS shares at $182.08; retains 119.1K shares; cross-ticker track record shows poorly-timed sells.

Charles Smith, Morgan Stanley's Chief Risk Officer, sold 8,500 shares at $182.08 on 2026-01-20, reducing holdings by 6.7% to 119.1K shares. The sale occurred at a price 4.3% below the 52-week high of $191.23, while MS has gained 2.0% in the past 30 days and 11.7% over 90 days. Smith's cross-ticker track record across 2 prior sells shows an average 90-day return of 16.9%, with a 0.00% well-timed rate—indicating his prior sales executed before subsequent stock gains, not declines. At MS specifically, his 2 prior sells on 2025-07-17 and 2024-04-17 both resulted in positive 90-day returns (15.9% and 17.9% respectively), establishing a pattern of selling ahead of rallies rather than downturns. The fundamentals remain solid: $18.2B in latest-quarter revenue, $4.6B net income, 14.1% annual growth, and a P/E of 17.98, with current price at $183.05.

Morgan Stanley CRO Smith sells 20,000 shares ($2.8M) at $140.30; stock up 6.3% over 30 days, 29.0% over 90 days

Charles A. Smith, Chief Risk Officer of Morgan Stanley, sold 20,000 shares on 2025-07-17 at $140.30, reducing his stake from 139.2K to 119.2K shares (-14.4% of holdings) and generating $2,805,918.00 in proceeds. The sale occurred with the stock trading near its 52-week high (2.3% below the $144.14 peak) and following strong recent momentum: +6.3% over 30 days and +29.0% over 90 days. His prior open-market sell activity (1 cross-ticker instance) shows an average 90-day return of +17.9% after the sale, indicating his historical sells have preceded further gains rather than declines. At Morgan Stanley specifically, his one prior sale (2024-04-17) yielded 90-day post-sale gains of +17.9%, establishing a pattern where this CRO has sold into rallies without capturing subsequent appreciation.